Venus Medtech (Hangzhou) Inc. (the Company) issued an announcement pursuant to Rule 13.10 of the Listing Rules. According to the announcement, Cardiovalve Ltd., a wholly owned subsidiary of the Company, and MTH IP, L.P., a joint venture of the Company, have filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Edwards Lifesciences Corp. and Edwards Lifesciences LLC.
The Company confirmed it is not aware of any information that must be announced to avoid a false market in its securities or of any inside information requiring disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance. Shareholders and potential investors are advised to exercise caution when dealing in the Company’s shares.
The announcement is dated January 20, 2026.
Comments